Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Proteostasis' follow-on brings in $65M

    Proteostasis Therapeutics Inc. (NASDAQ:PTI) raised $65 million through the sale of 5 million shares at $13 in a follow-on underwritten by Leerink Partners, RBC Capital Markets, H.C. Wainwright and Baird.After market …

    Published on 9/9/2016
  • FINANCIAL NEWS: Sage raises $175M days after shares pop

    CNS company Sage Therapeutics Inc. (NASDAQ:SAGE) raised $175 million through the sale of 4.4 million shares at $39.75 in a follow-on underwritten by JPMorgan, Goldman Sachs, Cowen, Leerink, Canaccord Genuity and William…

    Published on 9/9/2016
  • FINANCIAL NEWS: Armune closes $5M series A round

    Diagnostics company Armune Bioscience Inc. (Kalamazoo, Mich.) closed its series A round at $5 million with the addition of investments from Grand Angels Venture Fund and the University of Michigan's Michigan Investment …

    Published on 9/8/2016
  • FINANCIAL NEWS: AveXis raises $136.6M in follow-on

    Gene therapy company AveXis Inc. (NASDAQ:AVXS) raised $136.6 million through the sale of 4 million shares at $34.50 in a follow-on underwritten by Goldman Sachs, Jefferies, BMO Capital Markets and Chardan. AveXis …

    Published on 9/8/2016
  • FINANCIAL NEWS: Chrono raises $47.6M in series B

    Drug delivery company Chrono Therapeutics Inc. raised $47.6 million in a series B round led by Kaiser Permanente Ventures. Endeavour Vision, Xeraya Capital Labuan, Asahi Kasei, Emergent Medical Partners, Hikma Ventures,…

    Published on 9/8/2016
  • FINANCIAL NEWS: Financial tracks

    Frazier Healthcare Partners said Kelly McCullum re-joined the firm as an operating partner on its growth buyout team. He was president and COO at TridentUSA Health Services (Burbank, Calif.).

    Published on 9/8/2016
  • FINANCIAL NEWS: IDbyDNA raises $9M for diagnostic software

    Infectious disease diagnostics developer IDbyDNA Inc. (Sunnyvale, Calif.) raised $9 million in a series A round led by Artis Ventures. Arup Laboratories (Salt Lake City, Utah) and other private investors also …

    Published on 9/8/2016
  • FINANCIAL NEWS: Pfizer, JDRF among newco AnTolRx's investors

    Diabetes newco AnTolRx Inc. (Cambridge, Mass.) raised $4 million in a series A round led by Pfizer Inc. (NYSE:PFE). Orion Equity Partners and JDRF also participated. AnTolRx is developing nanoparticles that combine an …

    Published on 9/8/2016
  • FINANCIAL NEWS: Financial tracks

    Frazier Healthcare named Brock Hardaway as an operating partner on its growth buyout team. He was CEO at Millennium Health (San Diego, Calif.).Water Street Healthcare Partners named Nicklaus Daley VP. He was an …

    Published on 9/7/2016
  • FINANCIAL NEWS: iBionext raises EUR 46M in growth fund's first close

    iBionext raised EUR 46 million ($51.4 million) in the first close of its iBionext Growth Fund. Launched earlier this year, the fund has a EUR 100 million ($111.8 million) target.iBionext launches and develops biotech, …

    Published on 9/7/2016
  • FINANCIAL NEWS: Moderna reveals new funding

    mRNA therapeutics company Moderna Therapeutics Inc. (Cambridge, Mass.) raised $474 million in a private round with existing institutional investors, its pharma partners and undisclosed new institutional investors. The …

    Published on 9/7/2016
  • FINANCIAL NEWS: Proclara raises $47M

    Protein misfolding company Proclara BioSciences Inc. (Cambridge, Mass.) raised $47 million in a series E round with existing investors, including undisclosed angels and Merieux Developpement. Proclara (formerly …

    Published on 9/7/2016
  • FINANCIAL NEWS: Rigontec raises EUR 15M for RIG-I agonists

    Rigontec GmbH (Bonn, Germany) raised EUR 15 million ($16.8 million) in the third and final close of its series A round. Existing investors Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech …

    Published on 9/6/2016
  • FINANCIAL NEWS: CBT raises $9.8M in series A

    Cancer company CBT Pharmaceuticals Inc. (Santa Clara, Calif.) raised $9.8 million in a series A round led by OrbiMed Asia. CBT's parent company is CRO Crown Bioscience International Inc. (TPex-E:6554), which seeded the …

    Published on 8/30/2016
  • FINANCIAL NEWS: Arcus discloses $119.7M in financings

    Immuno-oncology company Arcus Biosciences (Hayward, Calif.) emerged from stealth mode and disclosed it has raised $119.7 million raised in combined series A and B rounds. CEO Terry Rosen told BioCentury the company …

    Published on 8/29/2016
  • FINANCIAL NEWS: Cancer diagnostic play Mitra raises $27.4M

    Mitra Biotech Inc. (Boston, Mass.) raised $27.4 million in a series B round led by Sequoia India and Sands Capital Ventures. Other investors included RA Capital Management and existing investors Accel Partners and Tata …

    Published on 8/29/2016
  • FINANCIAL NEWS: Sofinnova Ventures raising $650M fund

    Sofinnova Ventures has raised $595.5 million toward Sofinnova Venture Partners X, its planned $650 million tenth fund, according to an SEC filing.Sofinnova closed its prior fund at $500 million in July 2014. The ninth …

    Published on 8/25/2016
  • FINANCIAL NEWS: Clarus co-founder Steinmetz passes away

    Clarus co-founder and Managing Director Michael Steinmetz passed away Aug. 6 from heart failure due to familial dilated cardiomyopathy, a heritable condition.In a notice posted on its website, Clarus said Steinmetz's …

    Published on 8/23/2016
  • FINANCIAL NEWS: Sophiris sinks after pricing discounted follow-on

    Sophiris Bio Inc. (NASDAQ:SPHS) raised $26 million through the sale of 6.5 million units at $4 in a follow-on underwritten by Piper Jaffray and Maxim. Each unit includes a share plus a warrant to acquire 0.75 shares. …

    Published on 8/23/2016
  • FINANCIAL NEWS: ABLS spinout raises $15M in series A round

    Allied Minds plc (LSE:ALM) said fibrosis and autoimmune start-up ABLS II LLC raised $15 million in a series A round. ABLS II is among three companies spun out from joint venture Allied-Bristol Life Sciences LLC, which …

    Published on 8/22/2016
  • FINANCIAL NEWS: Genomics company Singlera raises $20M

    Singlera Genomics Inc. (La Jolla, Calif.) raised $20 million in a series A round led by Lilly Asia Ventures. Green Pine Capital Partners and CDBI Partners also participated. The company is developing non-invasive …

    Published on 8/22/2016
  • FINANCIAL NEWS: Vyome's series C round brings in $14M

    Vyome Biosciences Pvt. Ltd. (New Delhi, India) raised $14 million in a series C round led by Perceptive Advisors and Romulus Capital. Existing investors including Kalaari Capital, Sabre Partners and Aarin Capital also …

    Published on 8/22/2016
  • FINANCIAL NEWS: Cambridge Innovation raises L75M

    Cambridge Innovation Capital plc raised L75 million ($97 million) in a private placement that included new investors Woodford Investment Management, Winton Ventures and the Oman Investment Fund. Existing shareholders …

    Published on 8/19/2016
  • FINANCIAL NEWS: Avelas' series C round brings in $20M

    Avelas Biosciences Inc. (La Jolla, Calif.) raised $20 million in a series C financing led by the Pharmstandard International S.A. subsidiary of Pharmstandard OJSC (RTS:PHST; LSE:PHST). New investors Ervington …

    Published on 8/18/2016
  • FINANCIAL NEWS: Nutrinia raises $30M in series D round

    Nutrinia Ltd. (Ramat Gan, Israel) raised $30 million in a series D round led by new investor TPG Biotech. New investors H.I.G. BioHealth Partners and WuXi Healthcare Ventures also participated, as did existing investors…

    Published on 8/18/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993